Related Experiment Video
Updated: Jul 20, 2025

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
Published on: August 20, 2007
Regulation of advanced therapies in Europe: Are we on the right track?
Ander Izeta1, Natividad Cuende2
1Donostia University Hospital and Biodonostia Health Research Institute, Advanced Therapies Unit, Paseo Dr. Begiristain s/n, 20014, Donostia-San Sebastian, Spain.
Abstract:
Sixteen years after regulating advanced therapy medicinal products (ATMPs) in the European Union, few ATMPs have gained marketing authorization. Additionally, market withdrawals for commercial reasons and a lack of reimbursement are de facto blocking patient access. Here, we pinpoint the major factors underlying this roadblock and how to circumvent it.
Related Concept Videos
Drug Regulation
Drug Control Governance: Regulatory Bodies and Their Impact
Clinical Trials: Overview
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
Preclinical Development: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...

